The European Medicines Agency has approved a key update for Wegovy, giving the treatment more flexibility during delivery. The decision allows Wegovy injections from Novo Nordisk to be kept at temperatures up to 30°C for as long as 48 hours...
India is moving quickly to secure methanol supply for pharma as West Asia crisis begin to strain imports of this key raw material. The methanol supply for pharma sector has come under pressure due to geopolitical tensions affecting...
India’s clinical trials ecosystem needs a serious upgrade, and Defense Minister Rajnath Singh made that clear today while urging the Armed Forces Medical Services (AFMS) to step up.
Aurobindo Pharma has approved the generic formulations transfer of its domestic branded generic formulations products business to its wholly owned subsidiary, Auropharm.
Emami has signed a deal to acquire full stake in Axiom Ayurveda, marking its entry into the fast-growing health and wellness beverage segment.
Biogen said it will acquire Apellis Pharmaceuticals for USD 5.6 billion, marking a major step in its rare disease strategy. The Biogen to buy Apellis deal comes as the company looks to reduce reliance on its aging multiple sclerosis portfolio and...
Indian pharmaceutical firms looking to benefit from the global biologics boom are facing major obstacles, as China's hold on biotech supply chains becomes even stronger.
Sanofi has secured a conditional marketing authorization for Rezurock (belumosudil) in the EU, marking a major step forward in chronic GVHD treatment.
Teva Pharmaceutical is accelerating its Teva’s biosimilars expansion with three major milestones that strengthen its “Pivot to Growth” strategy and reinforce its position in the global biosimilars market.
Government of India is stepping up its push for generic medicines in hospitals, urging healthcare providers to prescribe and stock low-cost alternatives to branded drugs.
, CDSCO.jpg)